ThermoGenesis Holdings, Inc.'s next confirmed earnings release is scheduled for November 17, 2026.
| Earnings Date | 11/17/2026 |
As of March 31, 2024, ThermoGenesis Holdings, Inc. has 7.95M shares outstanding.
| Shares Outstanding | 7.95M |
As of March 31, 2024, ThermoGenesis Holdings, Inc. maintains a current ratio of 0.52, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -637.17, indicating conservative leverage, while an interest coverage ratio of -0.91 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.52 |
| Quick Ratio | 0.28 |
| Debt / Equity | -637.17 |
| Debt / EBITDA | -1.00 |
| Interest Coverage | -0.91 |
Over the twelve months ended March 31, 2024, ThermoGenesis Holdings, Inc. posted a negative return on equity (ROE) of -417.94, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -98.83, reflecting losses generated across the asset base. The company generates approximately 291,212.12 in revenue per employee across its workforce of 33.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.25 indicates how many times ThermoGenesis Holdings, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -417.94 |
| Return on Assets (ROA) | -98.83 |
| Revenue Per Employee | 291,212.12 |
| Employee Count | 33.00 |
| Inventory Turnover | 3.25 |
As of the close on October 20, 2026, ThermoGenesis Holdings, Inc.'s stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.08.
| 200-Day Moving Average | 0.08 |
Over the twelve months ended March 31, 2024, ThermoGenesis Holdings, Inc. generated 9.61M in revenue and converted that into -14.74M in net income, yielding earnings per share of -4.98. EBITDA reached -6.91M, while operating income came in at -6.09M.
| Revenue | 9.61M |
| Gross Profit | 2.03M |
| Operating Income | -6.09M |
| Pretax Income | -15.74M |
| Net Income | -14.74M |
| EBITDA | -6.91M |
| EBIT | -8.12M |
| Earnings Per Share (EPS) | -4.98 |
As of March 31, 2024, ThermoGenesis Holdings, Inc. holds 1.18M in cash and equivalents against 6.93M in total debt, resulting in a net debt position of 3.03M. Total book value stands at 975,000.00, with working capital of -3.95M providing operational flexibility.
| Cash & Cash Equivalents | 1.18M |
| Total Debt | 6.93M |
| Net Debt | 3.03M |
| Equity (Book Value) | 975,000.00 |
| Book Value Per Share | 0.12 |
| Working Capital | -3.95M |
ThermoGenesis Holdings, Inc. produced -3.61M in operating cash flow over the twelve months ended March 31, 2024.
| Operating Cash Flow | -3.61M |
| Free Cash Flow | -3.61M |
| FCF Per Share | -1.14 |
Over the twelve months ended March 31, 2024, ThermoGenesis Holdings, Inc. posted a gross margin of 21.10, reflecting its pricing power and cost economics. The operating margin of -63.33 and net profit margin of -153.43 provide insight into operational efficiency.
| Gross Margin | 21.10 |
| Operating Margin | -63.33 |
| Pretax Margin | -163.77 |
| Profit Margin | -153.43 |
| EBITDA Margin | -71.88 |
ThermoGenesis Holdings, Inc.'s most recent stock split took place on December 22, 2022 with a 45:1 split ratio.
| Last Split Date | 12/22/2022 |
| Split Ratio | 45:1 |